These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2685829)

  • 21. Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1985 Mar; 109(3):349-54. PubMed ID: 3157586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apomorphine and pergolide induce hypothermia by stimulation of dopamine D-2 receptors.
    Ogren SO; Fuxe K
    Acta Physiol Scand; 1988 May; 133(1):91-5. PubMed ID: 3067517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.
    Beninger RJ; Cheng M; Hahn BL; Hoffman DC; Mazurski EJ; Morency MA; Ramm P; Stewart RJ
    Psychopharmacology (Berl); 1987; 92(3):343-9. PubMed ID: 2957718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.
    Cousins MS; Wei W; Salamone JD
    Psychopharmacology (Berl); 1994 Dec; 116(4):529-37. PubMed ID: 7701059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.
    Christensen AV; Arnt J; Hyttel J; Larsen JJ; Svendsen O
    Life Sci; 1984 Apr; 34(16):1529-40. PubMed ID: 6144029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of D1 and D2 dopamine antagonists on behavior of polydipsic rats.
    Todd KG; Beck CH; Martin-Iverson MT
    Pharmacol Biochem Behav; 1992 Jul; 42(3):381-8. PubMed ID: 1409772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer.
    Smith JK; Neill JC; Costall B
    Pharmacol Biochem Behav; 1997 Aug; 57(4):843-9. PubMed ID: 9259014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis.
    Morelli M; Longoni R; Spina L; Di Chiara G
    Psychopharmacology (Berl); 1986; 89(2):259-60. PubMed ID: 3088647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys.
    Woolverton WL; Kamien JB; Goldberg LI
    J Pharmacol Exp Ther; 1987 Apr; 241(1):213-7. PubMed ID: 3553538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
    Chipkin RE
    Pharmacol Biochem Behav; 1988 Jul; 30(3):683-6. PubMed ID: 2974995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms.
    Broersen LM; Heinsbroek RP; de Bruin JP; Uylings HB; Olivier B
    Brain Res; 1995 Mar; 674(2):221-9. PubMed ID: 7796100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apomorphine-induced penile erection and yawning: site of action in brain.
    Melis MR; Argiolas A; Gessa GL
    Brain Res; 1987 Jul; 415(1):98-104. PubMed ID: 3497688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA; Pokora MJ; Widzowski DV
    Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reduction of water intake in rats caused by a low dose of apomorphine is unaltered by alpha-methyl-p-tyrosine: are autoreceptors not involved?
    Ljungberg T; Ståhle L
    J Neural Transm Gen Sect; 1989; 78(3):265-9. PubMed ID: 2803702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance.
    Aberman JE; Ward SJ; Salamone JD
    Pharmacol Biochem Behav; 1998 Dec; 61(4):341-8. PubMed ID: 9802826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of apomorphine on oxytocin concentrations in different brain areas and plasma of male rats.
    Melis MR; Argiolas A; Stancampiano R; Gessa GL
    Eur J Pharmacol; 1990 Jun; 182(1):101-7. PubMed ID: 2205505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.